Abstract

Psoriasis

Author(s): Fenrich Jon, Vidaurri Vincent

Issue: Sep/Oct 2000 - Compounding for Immune System Disorders

Page(s): 346

Download in electronic PDF format for $75

Abstract

Psoriasis is a common skin disorder affecting around 2% of the US population. This article provides an overview of its causes, pathogenesis and therapeutic options. The authors end their discussion by suggesting that compounding pharmacists have more comprehensive tools to treat such diseases than those available to the average ambulatory pharmacist and that disseminating knowledge about the use of agents in the compounding armamentarium promotes the quality of life of the psoriatic patient.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2000 Pg. 346	Psoriasis Author(s): Fenrich Jon, Vidaurri Vincent
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2023 Pg. 57	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 329	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Jul/Aug 2020 Pg. 337-345	Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
May/Jun 2011 Pg. 204-213	Treatment Options for Psoriasis Author(s): Williams LaVonn A, Humphreys Erica
Jan/Feb 1999 Pg. 34-35	Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor Author(s): Mason Dave
Jul/Aug 1998 Pg. 305	Psoriasis Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 382	Psoriasis Nail Treatment Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 383	Psoriasis Ointment, Heavy Moisturizing Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2023 Pg. 146	Cyclosporine Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 419	Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr